Xenon Pharmaceuticals Inc — Cash Flow (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 48.12 M69.5 M98.43 M145.33 M181.39 M279.12 M 279.12 M Cash from investing activities 16.82 M246.77 M296 M117.17 M165 M218 M 218 M Cash from financing activities 85.8 M447.54 M278.47 M353.52 M12.13 M117.11 M 117.11 M Free cash flow 45.49 M67.45 M95.54 M139.71 M178.31 M278.32 M 278.32 M

뉴스

제논 파마슈티컬 주식, 52주 신고가 경신

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Xenon earnings loom as investors brace for Phase 3 catalyst

울프 리서치, 제논 파마슈티컬스에 ’아웃퍼폼’ 등급 개시

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

파이퍼 샌들러, 뇌전증 임상 시험 관련 바이오헤이븐 주식 등급 재확인

Stifel, Xenon Pharmaceuticals 목표 주가 $66로 상향

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven stock rating upgraded by RBC Capital on promising CNS data

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12